Skip to main content

Advertisement

Log in

Clinical features and outcomes of anti-neutrophil cytoplasmic autoantibody-associated vasculitis in Chinese childhood-onset patients

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

Data on anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are limited in children. This study is to determine the clinical features and outcomes of childhood-onset AAV. A retrospective study was performed on patients who were diagnosed with AAV before 18 years old in Xiangya Hospital. Their medical records were analyzed by retrospective review. Sixteen patients were diagnosed with AAV before 18 years old in the past 9 years, with an average age of 13.3 ± 3.3 years and 13 of them were female. There were 15 patients with microscopic polyangiitis (MPA) and 1 with Wegener’s granulomatosis. The interval between onset of disease and diagnosis of AAV was 2 (1.5–3) months. Most patients (15/16, 93.8%) had multi-organ involvement, and all patients had renal involvement with 7 (43.8%) patients requiring dialysis at presentation. Eleven patients underwent a renal biopsy, of which mixed class and sclerotic class were the most two common histological types. All patients received immunosuppressive therapy for induction therapy including intravenous administrations of methylprednisolone (MP) pulse therapy for 8 patients. 8 patients (50%) achieved remission after induction therapy. After a median follow-up of 46.3 ± 36.1 months, nine (56.3%) patients progressed to end-stage renal disease (ESRD) and 5 (31.3%) patients died. Childhood-onset AAV showed similar clinical and pathological features compared to those of adults, except that it usually occurs in girls. The most commonly involved organ was the kidney, and it had a high risk of progression to ESRD. Early diagnosis and initiation of appropriate immunomodulatory therapy would be important to improve outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Ponte C, Agueda AF, Luqmani RA. Clinical features and structured clinical evaluation of vasculitis. Best Pract Res Clin Rheumatol. 2018;32(1):31–51.

    Article  CAS  Google Scholar 

  2. Hamour SM, Salama AD. ANCA comes of age-but with caveats. Kidney Int. 2011;79(7):699–701.

    Article  Google Scholar 

  3. Jariwala M, Laxer RM. Childhood GPA, EGPA, and MPA. Clin Immunol. 2020;211:108325.

    Article  CAS  Google Scholar 

  4. Jariwala MP, Laxer RM. Primary vasculitis in childhood: GPA and MPA in childhood. Front Pediatr. 2018;6:226.

    Article  Google Scholar 

  5. Lee JJY, Alsaleem A, Chiang GPK, et al. Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist. Pediatr Rheumatol Online J. 2019;17(1):31.

    Article  Google Scholar 

  6. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11.

    Article  CAS  Google Scholar 

  7. Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68(12):1827–32.

    Article  CAS  Google Scholar 

  8. Dolezalova P, Price-Kuehne FE, Ozen S, et al. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis. 2013;72(10):1628–33.

    Article  Google Scholar 

  9. Hellmich B, Flossmann O, Gross WL, et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2007;66(5):605–17.

    Article  CAS  Google Scholar 

  10. Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10):1628–36.

    Article  Google Scholar 

  11. Chen YX, Xu J, Pan XX, et al. Histopathological classification and renal outcome in patients with antineutrophil cytoplasmic antibodies-associated renal vasculitis: a study of 186 patients and metaanalysis. J Rheumatol. 2017;44(3):304–13.

    Article  Google Scholar 

  12. Calatroni M, Oliva E, Gianfreda D, et al. ANCA-associated vasculitis in childhood: recent advances. Ital J Pediatr. 2017;43(1):46.

    Article  Google Scholar 

  13. Hirano D, Ishikawa T, Inaba A, et al. Epidemiology and clinical features of childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis: a clinicopathological analysis. Pediatr Nephrol. 2019;34(8):1425–33.

    Article  Google Scholar 

  14. Iudici M, Puechal X, Pagnoux C, et al. Brief report: childhood-onset systemic necrotizing vasculitides: long-term data from the french vasculitis study group registry. Arthritis Rheumatol. 2015;67(7):1959–65.

    Article  Google Scholar 

  15. Yu F, Huang JP, Zou WZ, Zhao MH. The clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children. Pediatr Nephrol. 2006;21(4):497–502.

    Article  Google Scholar 

  16. Meng T, Zhong Y, Chen J, et al. Clinical features and outcomes of anti-neutrophil cytoplasmic autoantibody-associated vasculitis in Chinese elderly and very elderly patients. Int Urol Nephrol. 2021;53(9):1875–81.

    Article  CAS  Google Scholar 

  17. Xin G, Zhao MH, Wang HY. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in Chinese patients with clinically suspected vasculitis. Clin Diagn Lab Immunol. 2004;11(3):559–62.

    PubMed  PubMed Central  Google Scholar 

  18. Jennette JC, Nachman PH. ANCA glomerulonephritis and vasculitis. Clin J Am Soc Nephrol. 2017;12(10):1680–91.

    Article  Google Scholar 

  19. Wang HY, Cui Z, Pei ZY, et al. Risk HLA class II alleles and amino acid residues in myeloperoxidase-ANCA-associated vasculitis. Kidney Int. 2019;96(4):1010–9.

    Article  CAS  Google Scholar 

  20. Wu J, Pei Y, Rong L, et al. Clinicopathological analysis of 34 cases of primary antineutrophil cytoplasmic antibody-associated vasculitis in Chinese children. Front Pediatr. 2021;9:656307.

    Article  Google Scholar 

  21. Sun L, Wang H, Jiang X, et al. Clinical and pathological features of microscopic polyangiitis in 20 children. J Rheumatol. 2014;41(8):1712–9.

    Article  Google Scholar 

  22. Huang L, Zhong Y, Ooi JD, et al. The effect of pulse methylprednisolone induction therapy in Chinese patients with dialysis-dependent MPO-ANCA associated vasculitis. Int Immunopharmacol. 2019;76:105883.

    Article  CAS  Google Scholar 

  23. Wu T, Zhong Y, Zhou Y, et al. Clinical characteristics and prognosis in 269 patients with antineutrophil cytoplasimc antibody associated vasculitis. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45(8):916–22.

    PubMed  Google Scholar 

  24. Zoshima T, Suzuki K, Suzuki F, et al. ANCA-associated nephritis without crescent formation has atypical clinicopathological features: a multicenter retrospective study. Clin Exp Nephrol. 2020;24(11):999–1006.

    Article  CAS  Google Scholar 

  25. Calatroni M, Consonni F, Allinovi M, et al.( 2021) Prognostic factors and long-term outcome with ANCA-associated kidney vasculitis in childhood. Clin J Am Soc Nephrol. Online ahead of print.

  26. Chang DY, Wu LH, Liu G, Chen M, Kallenberg CG, Zhao MH. Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant. 2012;27(6):2343–9.

    Article  Google Scholar 

  27. KDIGO Clinical Practice Guideline for Glomerulonephritis (2012). Chapter 13: Pauci-immune focal and segmental necrotizing glomerulonephritis. Kidney Int Suppl (2011). 2012;2(2):233–9.

  28. Bai YH, Li ZY, Chang DY, Chen M, Kallenberg CG, Zhao MH. The BVAS is an independent predictor of cardiovascular events and cardiovascular disease-related mortality in patients with ANCA-associated vasculitis: a study of 504 cases in a single Chinese center. Semin Arthritis Rheum. 2018;47(4):524–9.

    Article  Google Scholar 

  29. Flossmann O, Berden A, de Groot K, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011;70(3):488–94.

    Article  Google Scholar 

Download references

Funding

This work was funded by the National Natural Science Foundation of China (81800641 to TM), the National Key R&D Program of China (2020YFC2005000 to XX), the Key Research and Development Program of Hunan province (2018WK2060 to XX and 2020WK2008 to YZ), the Science and Technology Innovation Program of Hunan Province (2020RC5002 to JO), the Natural Science Foundation of Hunan Province (2021JJ31130 to YZ, 2020JJ6109 to CS and 2019JJ40515 to WN), and Chinese Society of Nephrology (18020010780 to YZ).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ya-Ou Zhou.

Ethics declarations

Conflict of interest

The authors report no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meng, T., Shen, C., Tang, R. et al. Clinical features and outcomes of anti-neutrophil cytoplasmic autoantibody-associated vasculitis in Chinese childhood-onset patients. Clin Exp Med 22, 447–453 (2022). https://doi.org/10.1007/s10238-021-00762-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-021-00762-4

Keywords

Navigation